Dental Tribune International
According to the ADA, it makes sense for COVID-19 point-of-care testing to be offered by dentists. (Photo:

ADA supports point-of-care COVID-19 testing by dentists

By Dental Tribune USA
November 06, 2020

CHICAGO, Ill., USA: According to a new policy from the American Dental Association, point-of-care testing to screen patients for chronic diseases and other medical conditions, including COVID-19, that could complicate dental care or put the patient and dental staff at risk is within a dentist’s scope of practice. “Yet currently, rapid and reliable COVID-19 tests are not available to dentists for in-office use, which makes no sense,” states ADA President Dr. Daniel Klemmedson.

Klemmedson, who holds degrees in both dentistry and medicine, points out that dentists are doctors of oral health. “It is well within dentists’ scope of practice to screen not just for COVID-19 infection but also other medical conditions that may affect dental care such as glucose levels, which help screen for diabetes, and blood pressure, which help screen for hypertension. Patients with abnormal test results would be referred to a physician, other qualified medical professional or medical facility for diagnosis and follow-up care.”

“With strengthened infection prevention protocols and personal protective equipment (PPE), dental offices have re-opened safely around the country,” Klemmedson said. “Millions of patients have returned for oral health care, which is an essential health service. Dentists should be given access to FDA-authorized point-of-care testing for COVID-19 infection to add to their ability to screen patients and help to identify those infected with the virus.”

Klemmedson pointed out that dentists’ areas of care include not only their patients’ teeth, gums and supporting bone but also the muscles of the head, neck and jaw, the tongue, salivary glands, the nervous system of the head and neck and other areas. When appropriate, dentists perform procedures such as biopsies, and screen for chronic or infectious diseases, salivary gland function and oral cancer.

In addition, according to 2013-2016 data from the U.S. Centers for Disease Control and Prevention, 7.7% of people (10.2 million) reported having seen a dentist in the previous 12 months but no other medical professional.

“It makes practical sense for COVID-19 point of care testing to be included in screening procedures dentists perform,” Klemmedson said.

The U.S. Food and Drug Administration includes dentists among those professionals who can test for COVID-19. In addition, the CDC recommends dental facilities consider implementing pre-procedure testing for COVID-19, particularly during PPE shortages.

The ADA and state dental societies are actively advocating state and federal regulatory authorities to:

Publicly recognize that point-of-care testing for COVID-19 is within dentists’ existing scope of practice, and

Make COVID-19 tests available for use in dental practices.

“With dental practices reopened across the country, dentists are already screening patients for signs and symptoms of COVID-19, and referring patients for appropriate medical follow-up when indicated,” Klemmedson said. “Unfortunately, such screening alone will not identify all individuals who are infected. Identifying infected patients is key to being able to protect both patients and dental team members from exposure to the virus.”

Given that patients receiving dental treatment may be pre-symptomatic (infected but will develop symptoms in the next 14 days) or asymptomatic (infected but will never exhibit signs or symptoms of disease), Klemmedson said it is critical to identify those individuals carrying the virus so that it is possible to minimize their contacting and potentially infecting others.

(Source: ADA)

Related Content

February 24, 2020 | USA | News

Enhancing the customer experience

CHICAGO, Ill., USA: During the recent Chicago Dental Society Midwinter Meeting, the top executives from Henry Schein invited members of the dental industry media to a round-table discussion on the …


October 31, 2019 | USA | Business, News

NYU College of Dentistry hosts Shils Stars Dental Student Competition

NEW YORK, N.Y., USA: The Dr. Edward B. Shils Entrepreneurial Fund, a nonprofit organization dedicated to innovation in health care, held its third annual Shils Stars Dental Student Competition and …


October 11, 2018 | USA | Events, News

Gen. Colin Powell delivers keynote at 2018 AAOMS meeting

CHICAGO, Ill., USA: Gen. Colin L. Powell delivered the keynote address to a standing-room-only audience Oct. 10 at the 100th meeting of the American Association of Oral and Maxillofacial Surgeons.

  1. Juan Fausto Tapia says:

    Efectivamente, utilizar instrumental o productos falsificados conlleva a poner en peligro la salud del paciente y pone en riesgo el trabajo del profesional al manipular elementos que no están confeccionados con los estándares requeridos.

  2. Juana Patricia Zavala Matulic says:

    Son muy buenos productos, lamentablemente compre falsificados en Chile, en Dental Laval, hace 5 años atrás, nunca más les compré nada

  3. Simcha Grieve says:

    I have TMJ issues due to a no longer anatomically correct jaw as a result of the unnecessary removal of my fully erupted wisdom teeth. I’ll be glad to have a conversation about regrowing my wisdom teeth in whatever capacity that could be possible. Having my wisdom teeth back would improve my life a great great day.

  4. Usha Bisht says:

    On 5th Nov,2020 tested with Covid Positive with ct 19 and now on 21st again tested with Covid Positive with ct 30. Now, when I have to test again for negative

  5. vidya audri utamy says:

    may i get these PDF journal, please ?

  6. Pankajkumar omprakash gujarati says:

    N gene(ct value)15
    ORF 1ab(ct value)15
    S gene(ct value). 16
    My report pls tell me law or high virus

  7. Pankajkumar omprakash gujarati says:

    N gene(ct value)15
    ORF 1ab(ct value)15
    S gene(ct value). 16
    It is low or strong

  8. Sayantan Samanta says:

    RdRp + N GENE :33.6
    It is low or strong ??

  9. Praveen Goyal says:

    My N gene CT Value is 19.82 and ORF1ab gene CT value is 17.21. my age is 35 i got positive report.
    pls advise

  10. Pradeep says:

    Screening (E gene) Ct Value Confirmatory (RdRp & N gene) Ct Value
    24.95 26.75
    and my age is 56 what is it , I kno it’s a low virus detected and non communicable but what are the risk factors

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2020 - All rights reserved - Dental Tribune International